Clinical Trials
5
Active:0
Completed:2
Trial Phases
1 Phases
Phase 3:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
3 (100.0%)A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
Phase 3
Recruiting
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Biological: CLS2901C (human [allogeneic] chondrocyte sheets)
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- CellSeed Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT06549686
- Locations
- 🇯🇵
Ebina General Hospital/Ebina Medical Plaza, Ebina, Kanagawa, Japan
🇯🇵Tokai University Hospital, Isehara, Kanagawa, Japan
🇯🇵Yokohama Sekishinkai Hospital, Yokohama, Kanagawa, Japan
A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group
Phase 3
Terminated
- Conditions
- Superficial Esophageal Cancer
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- CellSeed Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT04689594
- Locations
- 🇯🇵
Okayama University Hospital, Okayama, Japan
Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer
Phase 3
Completed
- Conditions
- Superficial Esophageal Cancer
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2019-03-07
- Lead Sponsor
- CellSeed Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02866019
- Locations
- 🇯🇵
National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
🇯🇵National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
🇯🇵Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan
News
No news found